The Empiric Enthusiasm and Evidence-Based Disappointments of Drug Therapy in COVID

The Empiric Enthusiasm and Evidence-Based Disappointments of Drug Therapy in COVID

The Empiric Enthusiasm and Evidence-Based Disappointments of Drug Therapy in COVID

Family MedicineGeneral PracticeInternal MedicineInfectious Diseases
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 1 hour | A black calendar with white triangle in center that has a black exclamation point in the middle 16 Mar 2023 

Overview

About this course

The wide gamut of therapeutic options for coronavirus disease 2019 (COVID-19) is growing and evolving rapidly as researchers try to understand the disease pathophysiology as the pandemic continues. Current management of COVID-19 focuses on prevention of infection, control measures, and supportive care during hospitalization. Different countries have approved the use of different drugs against COVID-19 to help prevent progression of the disease to a more serious illness in susceptible individuals. This e-learning module provides a summary of the current available evidence on the different therapies used against COVID-19.


Learning outcomes

Upon completion of the educational activity, participants should be able to:
  • Identify the current approved treatment options for COVID-19

Topics covered

  • Discussion of drug trials
  • Supportive therapy for COVID-19

1 CPD Point Available